PLG and androgen insensitivity syndrome: The only drug currently approved to treat acute ischemic stroke (AIS) caused by pathological thrombus formation is recombinant tissue plasminogen activator (rtPA), which targets lysis of fibrin-rich clots via conversion of plasminogen into its active form, plasmin.